Global Antibody Services Market Analysis and Forecast 2024-2030
Summary
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
According to APO Research, The global Antibody Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Antibody Services include ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad and Covance, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Antibody Services, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antibody Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody Services revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antibody Services revenue, projected growth trends, production technology, application and end-user industry.
Antibody Services segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Antibody Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Antibody Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Services revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
According to APO Research, The global Antibody Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Antibody Services include ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad and Covance, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Antibody Services, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antibody Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody Services revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antibody Services revenue, projected growth trends, production technology, application and end-user industry.
Antibody Services segment by Company
- ThermoFisher
- GenScript
- Abcam
- MBS
- ROCKLAND
- ProSci
- Anaspec
- Bio-Rad
- Covance
- Capra Science
- Innovagen
- APS
- Randox
- GL Biochem
- Abgent
- Monoclonal
- Polyclonal
- Others
- BioScience Companies
- BioScience Research Institutions
- Hospitals
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Antibody Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Antibody Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Services revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Antibody Services Market by Type
1.2.1 Global Antibody Services Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal
1.2.3 Polyclonal
1.2.4 Others
1.3 Antibody Services Market by Application
1.3.1 Global Antibody Services Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 BioScience Companies
1.3.3 BioScience Research Institutions
1.3.4 Hospitals
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 ANTIBODY SERVICES MARKET DYNAMICS
2.1 Antibody Services Industry Trends
2.2 Antibody Services Industry Drivers
2.3 Antibody Services Industry Opportunities and Challenges
2.4 Antibody Services Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Antibody Services Market Perspective (2019-2030)
3.2 Global Antibody Services Growth Trends by Region
3.2.1 Global Antibody Services Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Antibody Services Market Size by Region (2019-2024)
3.2.3 Global Antibody Services Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Antibody Services Revenue by Players
4.1.1 Global Antibody Services Revenue by Players (2019-2024)
4.1.2 Global Antibody Services Revenue Market Share by Players (2019-2024)
4.1.3 Global Antibody Services Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Antibody Services Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Antibody Services Key Players Headquarters & Area Served
4.4 Global Antibody Services Players, Product Type & Application
4.5 Global Antibody Services Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Antibody Services Market CR5 and HHI
4.6.2 Global Top 5 and 10 Antibody Services Players Market Share by Revenue in 2023
4.6.3 2023 Antibody Services Tier 1, Tier 2, and Tier
5 ANTIBODY SERVICES MARKET SIZE BY TYPE
5.1 Global Antibody Services Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Antibody Services Revenue by Type (2019-2030)
5.3 Global Antibody Services Revenue Market Share by Type (2019-2030)
6 ANTIBODY SERVICES MARKET SIZE BY APPLICATION
6.1 Global Antibody Services Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Antibody Services Revenue by Application (2019-2030)
6.3 Global Antibody Services Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 ThermoFisher
7.1.1 ThermoFisher Comapny Information
7.1.2 ThermoFisher Business Overview
7.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2019-2024)
7.1.4 ThermoFisher Antibody Services Product Portfolio
7.1.5 ThermoFisher Recent Developments
7.2 GenScript
7.2.1 GenScript Comapny Information
7.2.2 GenScript Business Overview
7.2.3 GenScript Antibody Services Revenue and Gross Margin (2019-2024)
7.2.4 GenScript Antibody Services Product Portfolio
7.2.5 GenScript Recent Developments
7.3 Abcam
7.3.1 Abcam Comapny Information
7.3.2 Abcam Business Overview
7.3.3 Abcam Antibody Services Revenue and Gross Margin (2019-2024)
7.3.4 Abcam Antibody Services Product Portfolio
7.3.5 Abcam Recent Developments
7.4 MBS
7.4.1 MBS Comapny Information
7.4.2 MBS Business Overview
7.4.3 MBS Antibody Services Revenue and Gross Margin (2019-2024)
7.4.4 MBS Antibody Services Product Portfolio
7.4.5 MBS Recent Developments
7.5 ROCKLAND
7.5.1 ROCKLAND Comapny Information
7.5.2 ROCKLAND Business Overview
7.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2019-2024)
7.5.4 ROCKLAND Antibody Services Product Portfolio
7.5.5 ROCKLAND Recent Developments
7.6 ProSci
7.6.1 ProSci Comapny Information
7.6.2 ProSci Business Overview
7.6.3 ProSci Antibody Services Revenue and Gross Margin (2019-2024)
7.6.4 ProSci Antibody Services Product Portfolio
7.6.5 ProSci Recent Developments
7.7 Anaspec
7.7.1 Anaspec Comapny Information
7.7.2 Anaspec Business Overview
7.7.3 Anaspec Antibody Services Revenue and Gross Margin (2019-2024)
7.7.4 Anaspec Antibody Services Product Portfolio
7.7.5 Anaspec Recent Developments
7.8 Bio-Rad
7.8.1 Bio-Rad Comapny Information
7.8.2 Bio-Rad Business Overview
7.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2019-2024)
7.8.4 Bio-Rad Antibody Services Product Portfolio
7.8.5 Bio-Rad Recent Developments
7.9 Covance
7.9.1 Covance Comapny Information
7.9.2 Covance Business Overview
7.9.3 Covance Antibody Services Revenue and Gross Margin (2019-2024)
7.9.4 Covance Antibody Services Product Portfolio
7.9.5 Covance Recent Developments
7.10 Capra Science
7.10.1 Capra Science Comapny Information
7.10.2 Capra Science Business Overview
7.10.3 Capra Science Antibody Services Revenue and Gross Margin (2019-2024)
7.10.4 Capra Science Antibody Services Product Portfolio
7.10.5 Capra Science Recent Developments
7.11 Innovagen
7.11.1 Innovagen Comapny Information
7.11.2 Innovagen Business Overview
7.11.3 Innovagen Antibody Services Revenue and Gross Margin (2019-2024)
7.11.4 Innovagen Antibody Services Product Portfolio
7.11.5 Innovagen Recent Developments
7.12 APS
7.12.1 APS Comapny Information
7.12.2 APS Business Overview
7.12.3 APS Antibody Services Revenue and Gross Margin (2019-2024)
7.12.4 APS Antibody Services Product Portfolio
7.12.5 APS Recent Developments
7.13 Randox
7.13.1 Randox Comapny Information
7.13.2 Randox Business Overview
7.13.3 Randox Antibody Services Revenue and Gross Margin (2019-2024)
7.13.4 Randox Antibody Services Product Portfolio
7.13.5 Randox Recent Developments
7.14 GL Biochem
7.14.1 GL Biochem Comapny Information
7.14.2 GL Biochem Business Overview
7.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2019-2024)
7.14.4 GL Biochem Antibody Services Product Portfolio
7.14.5 GL Biochem Recent Developments
7.15 Abgent
7.15.1 Abgent Comapny Information
7.15.2 Abgent Business Overview
7.15.3 Abgent Antibody Services Revenue and Gross Margin (2019-2024)
7.15.4 Abgent Antibody Services Product Portfolio
7.15.5 Abgent Recent Developments
8 NORTH AMERICA
8.1 North America Antibody Services Revenue (2019-2030)
8.2 North America Antibody Services Revenue by Type (2019-2030)
8.2.1 North America Antibody Services Revenue by Type (2019-2024)
8.2.2 North America Antibody Services Revenue by Type (2025-2030)
8.3 North America Antibody Services Revenue Share by Type (2019-2030)
8.4 North America Antibody Services Revenue by Application (2019-2030)
8.4.1 North America Antibody Services Revenue by Application (2019-2024)
8.4.2 North America Antibody Services Revenue by Application (2025-2030)
8.5 North America Antibody Services Revenue Share by Application (2019-2030)
8.6 North America Antibody Services Revenue by Country
8.6.1 North America Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Antibody Services Revenue by Country (2019-2024)
8.6.3 North America Antibody Services Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Antibody Services Revenue (2019-2030)
9.2 Europe Antibody Services Revenue by Type (2019-2030)
9.2.1 Europe Antibody Services Revenue by Type (2019-2024)
9.2.2 Europe Antibody Services Revenue by Type (2025-2030)
9.3 Europe Antibody Services Revenue Share by Type (2019-2030)
9.4 Europe Antibody Services Revenue by Application (2019-2030)
9.4.1 Europe Antibody Services Revenue by Application (2019-2024)
9.4.2 Europe Antibody Services Revenue by Application (2025-2030)
9.5 Europe Antibody Services Revenue Share by Application (2019-2030)
9.6 Europe Antibody Services Revenue by Country
9.6.1 Europe Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Antibody Services Revenue by Country (2019-2024)
9.6.3 Europe Antibody Services Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Antibody Services Revenue (2019-2030)
10.2 China Antibody Services Revenue by Type (2019-2030)
10.2.1 China Antibody Services Revenue by Type (2019-2024)
10.2.2 China Antibody Services Revenue by Type (2025-2030)
10.3 China Antibody Services Revenue Share by Type (2019-2030)
10.4 China Antibody Services Revenue by Application (2019-2030)
10.4.1 China Antibody Services Revenue by Application (2019-2024)
10.4.2 China Antibody Services Revenue by Application (2025-2030)
10.5 China Antibody Services Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Antibody Services Revenue (2019-2030)
11.2 Asia Antibody Services Revenue by Type (2019-2030)
11.2.1 Asia Antibody Services Revenue by Type (2019-2024)
11.2.2 Asia Antibody Services Revenue by Type (2025-2030)
11.3 Asia Antibody Services Revenue Share by Type (2019-2030)
11.4 Asia Antibody Services Revenue by Application (2019-2030)
11.4.1 Asia Antibody Services Revenue by Application (2019-2024)
11.4.2 Asia Antibody Services Revenue by Application (2025-2030)
11.5 Asia Antibody Services Revenue Share by Application (2019-2030)
11.6 Asia Antibody Services Revenue by Country
11.6.1 Asia Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Antibody Services Revenue by Country (2019-2024)
11.6.3 Asia Antibody Services Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Antibody Services Revenue (2019-2030)
12.2 MEALA Antibody Services Revenue by Type (2019-2030)
12.2.1 MEALA Antibody Services Revenue by Type (2019-2024)
12.2.2 MEALA Antibody Services Revenue by Type (2025-2030)
12.3 MEALA Antibody Services Revenue Share by Type (2019-2030)
12.4 MEALA Antibody Services Revenue by Application (2019-2030)
12.4.1 MEALA Antibody Services Revenue by Application (2019-2024)
12.4.2 MEALA Antibody Services Revenue by Application (2025-2030)
12.5 MEALA Antibody Services Revenue Share by Application (2019-2030)
12.6 MEALA Antibody Services Revenue by Country
12.6.1 MEALA Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Antibody Services Revenue by Country (2019-2024)
12.6.3 MEALA Antibody Services Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Antibody Services Market by Type
1.2.1 Global Antibody Services Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal
1.2.3 Polyclonal
1.2.4 Others
1.3 Antibody Services Market by Application
1.3.1 Global Antibody Services Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 BioScience Companies
1.3.3 BioScience Research Institutions
1.3.4 Hospitals
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 ANTIBODY SERVICES MARKET DYNAMICS
2.1 Antibody Services Industry Trends
2.2 Antibody Services Industry Drivers
2.3 Antibody Services Industry Opportunities and Challenges
2.4 Antibody Services Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Antibody Services Market Perspective (2019-2030)
3.2 Global Antibody Services Growth Trends by Region
3.2.1 Global Antibody Services Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Antibody Services Market Size by Region (2019-2024)
3.2.3 Global Antibody Services Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Antibody Services Revenue by Players
4.1.1 Global Antibody Services Revenue by Players (2019-2024)
4.1.2 Global Antibody Services Revenue Market Share by Players (2019-2024)
4.1.3 Global Antibody Services Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Antibody Services Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Antibody Services Key Players Headquarters & Area Served
4.4 Global Antibody Services Players, Product Type & Application
4.5 Global Antibody Services Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Antibody Services Market CR5 and HHI
4.6.2 Global Top 5 and 10 Antibody Services Players Market Share by Revenue in 2023
4.6.3 2023 Antibody Services Tier 1, Tier 2, and Tier
5 ANTIBODY SERVICES MARKET SIZE BY TYPE
5.1 Global Antibody Services Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Antibody Services Revenue by Type (2019-2030)
5.3 Global Antibody Services Revenue Market Share by Type (2019-2030)
6 ANTIBODY SERVICES MARKET SIZE BY APPLICATION
6.1 Global Antibody Services Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Antibody Services Revenue by Application (2019-2030)
6.3 Global Antibody Services Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 ThermoFisher
7.1.1 ThermoFisher Comapny Information
7.1.2 ThermoFisher Business Overview
7.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2019-2024)
7.1.4 ThermoFisher Antibody Services Product Portfolio
7.1.5 ThermoFisher Recent Developments
7.2 GenScript
7.2.1 GenScript Comapny Information
7.2.2 GenScript Business Overview
7.2.3 GenScript Antibody Services Revenue and Gross Margin (2019-2024)
7.2.4 GenScript Antibody Services Product Portfolio
7.2.5 GenScript Recent Developments
7.3 Abcam
7.3.1 Abcam Comapny Information
7.3.2 Abcam Business Overview
7.3.3 Abcam Antibody Services Revenue and Gross Margin (2019-2024)
7.3.4 Abcam Antibody Services Product Portfolio
7.3.5 Abcam Recent Developments
7.4 MBS
7.4.1 MBS Comapny Information
7.4.2 MBS Business Overview
7.4.3 MBS Antibody Services Revenue and Gross Margin (2019-2024)
7.4.4 MBS Antibody Services Product Portfolio
7.4.5 MBS Recent Developments
7.5 ROCKLAND
7.5.1 ROCKLAND Comapny Information
7.5.2 ROCKLAND Business Overview
7.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2019-2024)
7.5.4 ROCKLAND Antibody Services Product Portfolio
7.5.5 ROCKLAND Recent Developments
7.6 ProSci
7.6.1 ProSci Comapny Information
7.6.2 ProSci Business Overview
7.6.3 ProSci Antibody Services Revenue and Gross Margin (2019-2024)
7.6.4 ProSci Antibody Services Product Portfolio
7.6.5 ProSci Recent Developments
7.7 Anaspec
7.7.1 Anaspec Comapny Information
7.7.2 Anaspec Business Overview
7.7.3 Anaspec Antibody Services Revenue and Gross Margin (2019-2024)
7.7.4 Anaspec Antibody Services Product Portfolio
7.7.5 Anaspec Recent Developments
7.8 Bio-Rad
7.8.1 Bio-Rad Comapny Information
7.8.2 Bio-Rad Business Overview
7.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2019-2024)
7.8.4 Bio-Rad Antibody Services Product Portfolio
7.8.5 Bio-Rad Recent Developments
7.9 Covance
7.9.1 Covance Comapny Information
7.9.2 Covance Business Overview
7.9.3 Covance Antibody Services Revenue and Gross Margin (2019-2024)
7.9.4 Covance Antibody Services Product Portfolio
7.9.5 Covance Recent Developments
7.10 Capra Science
7.10.1 Capra Science Comapny Information
7.10.2 Capra Science Business Overview
7.10.3 Capra Science Antibody Services Revenue and Gross Margin (2019-2024)
7.10.4 Capra Science Antibody Services Product Portfolio
7.10.5 Capra Science Recent Developments
7.11 Innovagen
7.11.1 Innovagen Comapny Information
7.11.2 Innovagen Business Overview
7.11.3 Innovagen Antibody Services Revenue and Gross Margin (2019-2024)
7.11.4 Innovagen Antibody Services Product Portfolio
7.11.5 Innovagen Recent Developments
7.12 APS
7.12.1 APS Comapny Information
7.12.2 APS Business Overview
7.12.3 APS Antibody Services Revenue and Gross Margin (2019-2024)
7.12.4 APS Antibody Services Product Portfolio
7.12.5 APS Recent Developments
7.13 Randox
7.13.1 Randox Comapny Information
7.13.2 Randox Business Overview
7.13.3 Randox Antibody Services Revenue and Gross Margin (2019-2024)
7.13.4 Randox Antibody Services Product Portfolio
7.13.5 Randox Recent Developments
7.14 GL Biochem
7.14.1 GL Biochem Comapny Information
7.14.2 GL Biochem Business Overview
7.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2019-2024)
7.14.4 GL Biochem Antibody Services Product Portfolio
7.14.5 GL Biochem Recent Developments
7.15 Abgent
7.15.1 Abgent Comapny Information
7.15.2 Abgent Business Overview
7.15.3 Abgent Antibody Services Revenue and Gross Margin (2019-2024)
7.15.4 Abgent Antibody Services Product Portfolio
7.15.5 Abgent Recent Developments
8 NORTH AMERICA
8.1 North America Antibody Services Revenue (2019-2030)
8.2 North America Antibody Services Revenue by Type (2019-2030)
8.2.1 North America Antibody Services Revenue by Type (2019-2024)
8.2.2 North America Antibody Services Revenue by Type (2025-2030)
8.3 North America Antibody Services Revenue Share by Type (2019-2030)
8.4 North America Antibody Services Revenue by Application (2019-2030)
8.4.1 North America Antibody Services Revenue by Application (2019-2024)
8.4.2 North America Antibody Services Revenue by Application (2025-2030)
8.5 North America Antibody Services Revenue Share by Application (2019-2030)
8.6 North America Antibody Services Revenue by Country
8.6.1 North America Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Antibody Services Revenue by Country (2019-2024)
8.6.3 North America Antibody Services Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Antibody Services Revenue (2019-2030)
9.2 Europe Antibody Services Revenue by Type (2019-2030)
9.2.1 Europe Antibody Services Revenue by Type (2019-2024)
9.2.2 Europe Antibody Services Revenue by Type (2025-2030)
9.3 Europe Antibody Services Revenue Share by Type (2019-2030)
9.4 Europe Antibody Services Revenue by Application (2019-2030)
9.4.1 Europe Antibody Services Revenue by Application (2019-2024)
9.4.2 Europe Antibody Services Revenue by Application (2025-2030)
9.5 Europe Antibody Services Revenue Share by Application (2019-2030)
9.6 Europe Antibody Services Revenue by Country
9.6.1 Europe Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Antibody Services Revenue by Country (2019-2024)
9.6.3 Europe Antibody Services Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Antibody Services Revenue (2019-2030)
10.2 China Antibody Services Revenue by Type (2019-2030)
10.2.1 China Antibody Services Revenue by Type (2019-2024)
10.2.2 China Antibody Services Revenue by Type (2025-2030)
10.3 China Antibody Services Revenue Share by Type (2019-2030)
10.4 China Antibody Services Revenue by Application (2019-2030)
10.4.1 China Antibody Services Revenue by Application (2019-2024)
10.4.2 China Antibody Services Revenue by Application (2025-2030)
10.5 China Antibody Services Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Antibody Services Revenue (2019-2030)
11.2 Asia Antibody Services Revenue by Type (2019-2030)
11.2.1 Asia Antibody Services Revenue by Type (2019-2024)
11.2.2 Asia Antibody Services Revenue by Type (2025-2030)
11.3 Asia Antibody Services Revenue Share by Type (2019-2030)
11.4 Asia Antibody Services Revenue by Application (2019-2030)
11.4.1 Asia Antibody Services Revenue by Application (2019-2024)
11.4.2 Asia Antibody Services Revenue by Application (2025-2030)
11.5 Asia Antibody Services Revenue Share by Application (2019-2030)
11.6 Asia Antibody Services Revenue by Country
11.6.1 Asia Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Antibody Services Revenue by Country (2019-2024)
11.6.3 Asia Antibody Services Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Antibody Services Revenue (2019-2030)
12.2 MEALA Antibody Services Revenue by Type (2019-2030)
12.2.1 MEALA Antibody Services Revenue by Type (2019-2024)
12.2.2 MEALA Antibody Services Revenue by Type (2025-2030)
12.3 MEALA Antibody Services Revenue Share by Type (2019-2030)
12.4 MEALA Antibody Services Revenue by Application (2019-2030)
12.4.1 MEALA Antibody Services Revenue by Application (2019-2024)
12.4.2 MEALA Antibody Services Revenue by Application (2025-2030)
12.5 MEALA Antibody Services Revenue Share by Application (2019-2030)
12.6 MEALA Antibody Services Revenue by Country
12.6.1 MEALA Antibody Services Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Antibody Services Revenue by Country (2019-2024)
12.6.3 MEALA Antibody Services Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Global Antibody Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Monoclonal Major Manufacturers
Table 2. Polyclonal Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Antibody Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. BioScience Companies Major Manufacturers
Table 6. BioScience Research Institutions Major Manufacturers
Table 7. Hospitals Major Manufacturers
Table 8. Other Major Manufacturers
Table 9. Antibody Services Industry Trends
Table 10. Antibody Services Industry Drivers
Table 11. Antibody Services Industry Opportunities and Challenges
Table 12. Antibody Services Industry Restraints
Table 13. Global Antibody Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Antibody Services Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Antibody Services Market Share by Region (2019-2024)
Table 16. Global Antibody Services Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Antibody Services Market Share by Region (2025-2030)
Table 18. Global Antibody Services Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Antibody Services Revenue Market Share by Players (2019-2024)
Table 20. Global Antibody Services Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Antibody Services Key Players Headquarters & Area Served
Table 22. Global Antibody Services Players, Product Type & Application
Table 23. Global Antibody Services Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Antibody Services by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Antibody Services Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Antibody Services Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Antibody Services Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Antibody Services Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Antibody Services Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Antibody Services Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. ThermoFisher Company Information
Table 37. ThermoFisher Business Overview
Table 38. ThermoFisher Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. ThermoFisher Antibody Services Product Portfolio
Table 40. ThermoFisher Recent Development
Table 41. GenScript Company Information
Table 42. GenScript Business Overview
Table 43. GenScript Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. GenScript Antibody Services Product Portfolio
Table 45. GenScript Recent Development
Table 46. Abcam Company Information
Table 47. Abcam Business Overview
Table 48. Abcam Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Abcam Antibody Services Product Portfolio
Table 50. Abcam Recent Development
Table 51. MBS Company Information
Table 52. MBS Business Overview
Table 53. MBS Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. MBS Antibody Services Product Portfolio
Table 55. MBS Recent Development
Table 56. ROCKLAND Company Information
Table 57. ROCKLAND Business Overview
Table 58. ROCKLAND Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. ROCKLAND Antibody Services Product Portfolio
Table 60. ROCKLAND Recent Development
Table 61. ProSci Company Information
Table 62. ProSci Business Overview
Table 63. ProSci Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. ProSci Antibody Services Product Portfolio
Table 65. ProSci Recent Development
Table 66. Anaspec Company Information
Table 67. Anaspec Business Overview
Table 68. Anaspec Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Anaspec Antibody Services Product Portfolio
Table 70. Anaspec Recent Development
Table 71. Bio-Rad Company Information
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Bio-Rad Antibody Services Product Portfolio
Table 75. Bio-Rad Recent Development
Table 76. Covance Company Information
Table 77. Covance Business Overview
Table 78. Covance Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. Covance Antibody Services Product Portfolio
Table 80. Covance Recent Development
Table 81. Capra Science Company Information
Table 82. Capra Science Business Overview
Table 83. Capra Science Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Capra Science Antibody Services Product Portfolio
Table 85. Capra Science Recent Development
Table 86. Innovagen Company Information
Table 87. Innovagen Business Overview
Table 88. Innovagen Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Innovagen Antibody Services Product Portfolio
Table 90. Innovagen Recent Development
Table 91. APS Company Information
Table 92. APS Business Overview
Table 93. APS Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. APS Antibody Services Product Portfolio
Table 95. APS Recent Development
Table 96. Randox Company Information
Table 97. Randox Business Overview
Table 98. Randox Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Randox Antibody Services Product Portfolio
Table 100. Randox Recent Development
Table 101. GL Biochem Company Information
Table 102. GL Biochem Business Overview
Table 103. GL Biochem Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. GL Biochem Antibody Services Product Portfolio
Table 105. GL Biochem Recent Development
Table 106. Abgent Company Information
Table 107. Abgent Business Overview
Table 108. Abgent Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Abgent Antibody Services Product Portfolio
Table 110. Abgent Recent Development
Table 111. North America Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 112. North America Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 113. North America Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 115. North America Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 116. Europe Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 117. Europe Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 118. Europe Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. Europe Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 120. Europe Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 121. China Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 122. China Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 123. Asia Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 124. Asia Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 125. Asia Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 126. Asia Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 127. Asia Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 128. MEALA Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 129. MEALA Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 130. MEALA Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 131. MEALA Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 132. MEALA Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 133. Research Programs/Design for This Report
Table 134. Authors List of This Report
Table 135. Secondary Sources
Table 136. Primary Sources
Table 1. Global Antibody Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Monoclonal Major Manufacturers
Table 2. Polyclonal Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Antibody Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. BioScience Companies Major Manufacturers
Table 6. BioScience Research Institutions Major Manufacturers
Table 7. Hospitals Major Manufacturers
Table 8. Other Major Manufacturers
Table 9. Antibody Services Industry Trends
Table 10. Antibody Services Industry Drivers
Table 11. Antibody Services Industry Opportunities and Challenges
Table 12. Antibody Services Industry Restraints
Table 13. Global Antibody Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Antibody Services Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Antibody Services Market Share by Region (2019-2024)
Table 16. Global Antibody Services Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Antibody Services Market Share by Region (2025-2030)
Table 18. Global Antibody Services Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Antibody Services Revenue Market Share by Players (2019-2024)
Table 20. Global Antibody Services Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Antibody Services Key Players Headquarters & Area Served
Table 22. Global Antibody Services Players, Product Type & Application
Table 23. Global Antibody Services Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Antibody Services by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Antibody Services Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Antibody Services Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Antibody Services Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Antibody Services Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Antibody Services Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Antibody Services Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. ThermoFisher Company Information
Table 37. ThermoFisher Business Overview
Table 38. ThermoFisher Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. ThermoFisher Antibody Services Product Portfolio
Table 40. ThermoFisher Recent Development
Table 41. GenScript Company Information
Table 42. GenScript Business Overview
Table 43. GenScript Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. GenScript Antibody Services Product Portfolio
Table 45. GenScript Recent Development
Table 46. Abcam Company Information
Table 47. Abcam Business Overview
Table 48. Abcam Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Abcam Antibody Services Product Portfolio
Table 50. Abcam Recent Development
Table 51. MBS Company Information
Table 52. MBS Business Overview
Table 53. MBS Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. MBS Antibody Services Product Portfolio
Table 55. MBS Recent Development
Table 56. ROCKLAND Company Information
Table 57. ROCKLAND Business Overview
Table 58. ROCKLAND Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. ROCKLAND Antibody Services Product Portfolio
Table 60. ROCKLAND Recent Development
Table 61. ProSci Company Information
Table 62. ProSci Business Overview
Table 63. ProSci Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. ProSci Antibody Services Product Portfolio
Table 65. ProSci Recent Development
Table 66. Anaspec Company Information
Table 67. Anaspec Business Overview
Table 68. Anaspec Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Anaspec Antibody Services Product Portfolio
Table 70. Anaspec Recent Development
Table 71. Bio-Rad Company Information
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Bio-Rad Antibody Services Product Portfolio
Table 75. Bio-Rad Recent Development
Table 76. Covance Company Information
Table 77. Covance Business Overview
Table 78. Covance Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. Covance Antibody Services Product Portfolio
Table 80. Covance Recent Development
Table 81. Capra Science Company Information
Table 82. Capra Science Business Overview
Table 83. Capra Science Antibody Services Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Capra Science Antibody Services Product Portfolio
Table 85. Capra Science Recent Development
Table 86. Innovagen Company Information
Table 87. Innovagen Business Overview
Table 88. Innovagen Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Innovagen Antibody Services Product Portfolio
Table 90. Innovagen Recent Development
Table 91. APS Company Information
Table 92. APS Business Overview
Table 93. APS Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. APS Antibody Services Product Portfolio
Table 95. APS Recent Development
Table 96. Randox Company Information
Table 97. Randox Business Overview
Table 98. Randox Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Randox Antibody Services Product Portfolio
Table 100. Randox Recent Development
Table 101. GL Biochem Company Information
Table 102. GL Biochem Business Overview
Table 103. GL Biochem Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. GL Biochem Antibody Services Product Portfolio
Table 105. GL Biochem Recent Development
Table 106. Abgent Company Information
Table 107. Abgent Business Overview
Table 108. Abgent Antibody Services Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Abgent Antibody Services Product Portfolio
Table 110. Abgent Recent Development
Table 111. North America Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 112. North America Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 113. North America Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 115. North America Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 116. Europe Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 117. Europe Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 118. Europe Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. Europe Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 120. Europe Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 121. China Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 122. China Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 123. Asia Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 124. Asia Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 125. Asia Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 126. Asia Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 127. Asia Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 128. MEALA Antibody Services Revenue by Type (2019-2024) & (US$ Million)
Table 129. MEALA Antibody Services Revenue by Application (2019-2024) & (US$ Million)
Table 130. MEALA Antibody Services Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 131. MEALA Antibody Services Revenue by Country (2019-2024) & (US$ Million)
Table 132. MEALA Antibody Services Revenue by Country (2025-2030) & (US$ Million)
Table 133. Research Programs/Design for This Report
Table 134. Authors List of This Report
Table 135. Secondary Sources
Table 136. Primary Sources
LIST OF FIGURES
Figure 1. Antibody Services Product Picture
Figure 2. Global Antibody Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Antibody Services Market Size Share 2019 VS 2023 VS 2030
Figure 4. Monoclonal Picture
Figure 5. Polyclonal Picture
Figure 6. Others Picture
Figure 7. Global Antibody Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Antibody Services Market Size Share 2019 VS 2023 VS 2030
Figure 9. BioScience Companies Picture
Figure 10. BioScience Research Institutions Picture
Figure 11. Hospitals Picture
Figure 12. Other Picture
Figure 13. Global Antibody Services Market Size (US$ Million) & (2019-2030)
Figure 14. Global Antibody Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antibody Services Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Antibody Services Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Antibody Services Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Antibody Services Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Antibody Services Revenue Market Share by Type (2019-2030)
Figure 21. Global Antibody Services Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Antibody Services Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Antibody Services Revenue Market Share by Application (2019-2030)
Figure 24. North America Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Antibody Services Revenue Share by Type (2019-2030)
Figure 27. North America Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Antibody Services Revenue Share by Application (2019-2030)
Figure 29. North America Antibody Services Revenue Share by Country (2019-2030)
Figure 30. United States Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Antibody Services Revenue Share by Type (2019-2030)
Figure 35. Europe Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Antibody Services Revenue Share by Application (2019-2030)
Figure 37. Europe Antibody Services Revenue Share by Country (2019-2030)
Figure 38. Germany Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Antibody Services Revenue Share by Type (2019-2030)
Figure 47. China Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Antibody Services Revenue Share by Application (2019-2030)
Figure 49. Asia Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Antibody Services Revenue Share by Type (2019-2030)
Figure 52. Asia Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Antibody Services Revenue Share by Application (2019-2030)
Figure 54. Asia Antibody Services Revenue Share by Country (2019-2030)
Figure 55. Japan Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Antibody Services Revenue Share by Type (2019-2030)
Figure 64. MEALA Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Antibody Services Revenue Share by Application (2019-2030)
Figure 66. MEALA Antibody Services Revenue Share by Country (2019-2030)
Figure 67. Mexico Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
Figure 1. Antibody Services Product Picture
Figure 2. Global Antibody Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Antibody Services Market Size Share 2019 VS 2023 VS 2030
Figure 4. Monoclonal Picture
Figure 5. Polyclonal Picture
Figure 6. Others Picture
Figure 7. Global Antibody Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Antibody Services Market Size Share 2019 VS 2023 VS 2030
Figure 9. BioScience Companies Picture
Figure 10. BioScience Research Institutions Picture
Figure 11. Hospitals Picture
Figure 12. Other Picture
Figure 13. Global Antibody Services Market Size (US$ Million) & (2019-2030)
Figure 14. Global Antibody Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antibody Services Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Antibody Services Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Antibody Services Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Antibody Services Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Antibody Services Revenue Market Share by Type (2019-2030)
Figure 21. Global Antibody Services Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Antibody Services Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Antibody Services Revenue Market Share by Application (2019-2030)
Figure 24. North America Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Antibody Services Revenue Share by Type (2019-2030)
Figure 27. North America Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Antibody Services Revenue Share by Application (2019-2030)
Figure 29. North America Antibody Services Revenue Share by Country (2019-2030)
Figure 30. United States Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Antibody Services Revenue Share by Type (2019-2030)
Figure 35. Europe Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Antibody Services Revenue Share by Application (2019-2030)
Figure 37. Europe Antibody Services Revenue Share by Country (2019-2030)
Figure 38. Germany Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Antibody Services Revenue Share by Type (2019-2030)
Figure 47. China Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Antibody Services Revenue Share by Application (2019-2030)
Figure 49. Asia Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Antibody Services Revenue Share by Type (2019-2030)
Figure 52. Asia Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Antibody Services Revenue Share by Application (2019-2030)
Figure 54. Asia Antibody Services Revenue Share by Country (2019-2030)
Figure 55. Japan Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Antibody Services Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Antibody Services Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Antibody Services Revenue Share by Type (2019-2030)
Figure 64. MEALA Antibody Services Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Antibody Services Revenue Share by Application (2019-2030)
Figure 66. MEALA Antibody Services Revenue Share by Country (2019-2030)
Figure 67. Mexico Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Antibody Services Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
